Ma-Li Wong
#174,482
Most Influential Person Now
Brazilian-Australian psychiatrist
Ma-Li Wong's AcademicInfluence.com Rankings
Download Badge
Biology
Ma-Li Wong's Degrees
- Bachelors Medicine University of São Paulo
Why Is Ma-Li Wong Influential?
(Suggest an Edit or Addition)According to Wikipedia, Ma-Li Wong is an Australian researcher in the fields of psychiatry and pharmacogenomics, with a particular focus on major depression. She is head of the Pharmacogenomics Research Program in the Mind and Brain Theme at the South Australian Health and Medical Research Institute, as well as Strategic Professor of Psychiatry at Flinders University.
Ma-Li Wong's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response (2004) (720)
- From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways (2016) (601)
- Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. (2000) (551)
- Circadian interleukin-6 secretion and quantity and depth of sleep. (1999) (449)
- Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters (2012) (383)
- The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection (1999) (380)
- Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition (2015) (351)
- Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women. (1998) (307)
- Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response (2008) (266)
- Approaching the shared biology of obesity and depression: the stress axis as the locus of gene–environment interactions (2006) (259)
- The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress. (1999) (239)
- Pathways and mechanisms for cytokine signaling of the central nervous system. (1997) (219)
- Interleukin (IL) 1beta, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: pathophysiological implications. (1997) (212)
- Synchronicity of frequently sampled thyrotropin (TSH) and leptin concentrations in healthy adults and leptin-deficient subjects: evidence for possible partial TSH regulation by leptin in humans. (2001) (209)
- Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans (2004) (159)
- Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans (2009) (157)
- The nitric oxide hypothesis of aging (1998) (143)
- Endogenous interleukin-1 receptor antagonist is neuroprotective. (1997) (142)
- Ten years of leptin replacement therapy (2011) (117)
- Brain iNOS: current understanding and clinical implications. (1999) (115)
- Localization of interleukin-1 receptor antagonist mRNA in rat brain. (1991) (110)
- Expression of corticotropin releasing hormone receptors type I and type II mRNA in suicide victims and controls (2001) (104)
- Is increased antidepressant exposure a contributory factor to the obesity pandemic? (2016) (97)
- The procognitive effects of leptin in the brain and their clinical implications (2010) (97)
- Autoimmunity in autism (2002) (91)
- Localization of corticotropin-releasing hormone (CRH) receptor mRNA in adult rat brain by in situ hybridization histochemistry. (1994) (89)
- Localization of urocortin messenger RNA in rat brain and pituitary. (1996) (87)
- Prediction of susceptibility to major depression by a model of interactions of multiple functional genetic variants and environmental factors (2012) (84)
- Stress system abnormalities in melancholic and atypical depression: molecular, pathophysiological, and therapeutic implications. (1996) (80)
- APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer's disease (2015) (77)
- IL-1 beta, IL-1 receptor type I and iNOS gene expression in rat brain vasculature and perivascular areas. (1996) (75)
- Lower frequency of CYP2C9*2 in Mexican-Americans compared to Spaniards (2004) (64)
- St John's wort and imipramine-induced gene expression profiles identify cellular functions relevant to antidepressant action and novel pharmacogenetic candidates for the phenotype of antidepressant treatment response (2004) (61)
- Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress. (1999) (52)
- The Metabolic Syndrome - a global challenge for prevention. (2007) (49)
- Serotonergic neurons derived from induced pluripotent stem cells (iPSCs): a new pathway for research on the biology and pharmacology of major depression (2016) (48)
- CYP2C9 allele frequency differences between populations of Mexican-Mestizo, Mexican-Tepehuano, and Spaniards (2011) (48)
- Localization of interleukin 1 type I receptor mRNA in rat brain (1994) (46)
- Brain-derived neurotrophic factor (BDNF) in stress and affective disorders (2002) (45)
- Lipidomic profiling before and after Roux-en-Y gastric bypass in obese patients with diabetes (2013) (39)
- A molecular mechanism for stress-induced alterations in susceptibility to disease (1995) (35)
- Chromaffin cells: the peripheral brain (2012) (32)
- Long-term body weight outcomes of antidepressant–environment interactions (2010) (32)
- Is the worldwide epidemic of obesity a communicable feature of globalization? (2008) (31)
- Deconvolution of insulin secretion, insulin hepatic extraction post-hepatic delivery rates and sensitivity during 24-hour standardized meals: time course of glucose homeostasis in leptin replacement treatment. (2009) (30)
- Launching the ‘War on Mental Illness’ (2014) (29)
- Induction of constitutive heat shock protein 73 mRNA in the dentate gyrus by seizures. (1992) (29)
- Neutrophil-activating peptide-1/interleukin-8 mRNA is localized in rat hypothalamus and hippocampus. (1992) (28)
- Depression and cardiovascular disease: co-occurrence or shared genetic substrates? (2002) (27)
- Influence of admixture components on CYP2C9*2 allele frequency in eight indigenous populations from Northwest Mexico (2013) (27)
- Elevated cortisol levels and increased rates of diabetes and mood symptoms in Soviet Union-born Jewish immigrants to Germany (2005) (25)
- Activity-induced anorexia in rats does not affect hypothalamic neuropeptide gene expression chronically. (1993) (22)
- APOE * E 2 allele delays age of onset in PSEN 1 E 280 A Alzheimer ’ s disease (2015) (21)
- The prototypic antidepressant drug, imipramine, but not Hypericum perforatum (St. John's Wort), reduces HPA-axis function in the rat. (2003) (21)
- Localization of stem cell factor mRNA in adult rat hippocampus. (1994) (21)
- A novel conceptual framework for psychiatry: vertically and horizontally integrated approaches to redundancy and pleiotropism that co-exist with a classification of symptom clusters based on DSM-5 (2013) (20)
- Identification of hypothalamic transcripts upregulated by antidepressants. (1996) (20)
- Valproic acid enhances neuronal differentiation of sympathoadrenal progenitor cells (2015) (20)
- Advances in the pharmacogenomics of adverse drug reactions (2002) (20)
- Effects of leptin on lipid metabolism. (2008) (19)
- 150 years of Sigmund Freud: what would Freud have said about the obesity epidemic? (2006) (19)
- Stress-inducible-stem cells: a new view on endocrine, metabolic and mental disease? (2018) (19)
- A latent genetic subtype of major depression identified by whole-exome genotyping data in a Mexican-American cohort (2017) (18)
- Localization of interleukin-1 beta converting enzyme mRNA in rat brain vasculature: evidence that the genes encoding the interleukin-1 system are constitutively expressed in brain blood vessels. Pathophysiological implications. (1995) (18)
- Global meta-analysis of the C-11377G alteration in the ADIPOQ gene indicates the presence of population-specific effects: challenge for global health initiatives (2009) (18)
- The pharmacogenomics of depression (2001) (17)
- Cellular Immunity Before and After Leptin Replacement Therapy (2009) (17)
- Plasma leptin concentrations are highly correlated to emotional states throughout the day (2014) (17)
- Interleukin 1 receptor antagonist gene expression in rat pituitary in the systemic inflammatory response syndrome: pathophysiological implications (1997) (15)
- Advances in depression research: 2011 (2011) (15)
- Dysthymia in neurological disorders. (1996) (14)
- Chronic administration of anticonvulsants but not antidepressants impairs bone strength: clinical implications (2015) (14)
- The effects of stress on brain and adrenal stem cells (2016) (14)
- Peripheral is Central to the question (2005) (14)
- Pharmacogenomics in psychiatry: clinical issues to be considered (2005) (13)
- The evolution of signaling complexity suggests a mechanism for reducing the genomic search space in human association studies (2005) (13)
- Single nucleotide polymorphism identification in candidate gene systems of obesity (2001) (13)
- Depression and anxiety symptoms in diabetic patients on continuous subcutaneous insulin infusion (CSII) (2005) (13)
- Pulsatility of 24-hour concentrations of circulating interleukin-1-alpha in healthy women: analysis of integrated basal levels, discrete pulse properties, and correlation with simultaneous interleukin-2 concentrations. (1994) (10)
- Effects of leptin replacement on risk factors for cardiovascular disease in genetically leptin-deficient subjects. (2009) (10)
- Dopamine D2/D3 receptor availability in genetically leptin-deficient patients after long-term leptin replacement (2012) (9)
- The gene encoding for the novel transacting factor proopiomelanocortin corticotropin-releasing hormone responsive element binding protein 1 (PCRH-REB-1) is constitutively expressed in rat pituitary and in discrete brain regions containing CRH or CRH receptors: pathophysiological implications. (1995) (9)
- Translational research in psychiatry: pitfalls and opportunities for career development (2004) (9)
- Short-term antidepressant treatment has long-lasting effects, and reverses stress-induced decreases in bone features in rats (2019) (9)
- Dynamics of plasma proteome during leptin-replacement therapy in genetically based leptin deficiency (2011) (8)
- Pharmacogenomics of antidepressants: what is next? (2010) (6)
- Brain-derived neurotrophic factor in depression: a male problem? (2010) (6)
- The effects of stress on brain and adrenal stem cells. (2016) (6)
- Urinary Lipidomics: evidence for multiple sources and sexual dimorphism in healthy individuals (2017) (5)
- Will pharmacogenomics guide clinical practice? (2002) (5)
- Back to where it all started: monoamines and behavior—from drug responses to genes (2004) (5)
- Candidate Biomarkers for Systemic Inflammatory Response Syndrome and Inflammation: A Pathway for Novel Translational Therapeutics (2010) (5)
- Biological and behavioural antidepressant treatment responses with the selective serotonin reuptake inhibitor fluoxetine can be determined by the environment (2017) (5)
- Circumscribed lesion of the medial forebrain bundle area causes structural impairment of lymphoid organs and severe depression of immune function in rats (1998) (5)
- Pharmacogenomics in psychiatry: genomic considerations (2005) (4)
- Why does the United States need a national center for new cures? (2011) (3)
- Conceptualizing depression (2002) (3)
- Complexity and Pharmacogenomics (2002) (3)
- Interleukin 1 beta and fever. (1996) (3)
- Data from the Northern Finland 1966 Birth Cohort support an association between depression and immune function (2003) (2)
- Approaches to dissecting mechanisms of adverse drug reactions in psychiatry: clozapine-binding sites in the bone marrow (2003) (2)
- CYP2C9 and clinical response to antidepressant drugs in Mexican‐Americans (2005) (1)
- Sequence and function in pharmacogenomics (2003) (1)
- P.004 Deficiency in caspase 1, interferon-gamma receptor and nitric oxide synthase 2 alters depressive-, anxiety-like behaviour and gut microbiota (2019) (1)
- Molecular Psychiatry: Twenty years of progress from bench to clinic (2015) (0)
- An experimental therapeutic approach to genetically‐based obesity (2004) (0)
- P.2.a.027 Decreased anxiety and increased locomotor activity in caspase 1 knockout mice: evidence of antidepressant and anxiolytic effects (2014) (0)
- Monika Ehrhart-Bornstein, 1959–2015 (2016) (0)
- Distribution of stem cell factor mRNA in adult rat brain (1994) (0)
- Molecular Psychiatry: 20 Years (2015) (0)
- Patient-oriented investigation in pharmacogenomics (2002) (0)
This paper list is powered by the following services:
Other Resources About Ma-Li Wong
What Schools Are Affiliated With Ma-Li Wong?
Ma-Li Wong is affiliated with the following schools:
